Mersana Therapeutics Statistics

Total Valuation

MRSN has a market cap or net worth of $42.84 million. The enterprise value is -$34.83 million.

Market Cap	42.84M
Enterprise Value	-34.83M

Important Dates

The last earnings date was Thursday, May 15, 2025, before market open.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

MRSN has 124.63 million shares outstanding. The number of shares has increased by 3.10% in one year.

Current Share Class	124.63M
Shares Outstanding	124.63M
Shares Change (YoY)	+3.10%
Shares Change (QoQ)	+0.73%
Owned by Insiders (%)	1.97%
Owned by Institutions (%)	48.05%
Float	93.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.25
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.83

Current Ratio	1.83
Quick Ratio	1.76
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-21.07

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-30.90%
Return on Invested Capital (ROIC)	-173.22%
Return on Capital Employed (ROCE)	-141.50%
Revenue Per Employee	$333,392
Profits Per Employee	-$725,578
Employee Count	102
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

In the past 12 months, MRSN has paid $418,000 in taxes.

Income Tax	418,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.37% in the last 52 weeks. The beta is 1.30, so MRSN's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-85.37%
50-Day Moving Average	0.36
200-Day Moving Average	1.20
Relative Strength Index (RSI)	46.85
Average Volume (20 Days)	3,005,385

Short Selling Information

The latest short interest is 12.78 million, so 10.26% of the outstanding shares have been sold short.

Short Interest	12.78M
Short Previous Month	10.53M
Short % of Shares Out	10.26%
Short % of Float	13.62%
Short Ratio (days to cover)	5.42

Income Statement

In the last 12 months, MRSN had revenue of $34.01 million and -$74.01 million in losses. Loss per share was -$0.60.

Revenue	34.01M
Gross Profit	-38.67M
Operating Income	-76.85M
Pretax Income	-134.81M
Net Income	-74.01M
EBITDA	-75.33M
EBIT	-76.85M
Loss Per Share	-$0.60

Full Income Statement

Balance Sheet

The company has $102.29 million in cash and $24.62 million in debt, giving a net cash position of $77.66 million or $0.62 per share.

Cash & Cash Equivalents	102.29M
Total Debt	24.62M
Net Cash	77.66M
Net Cash Per Share	$0.62
Equity (Book Value)	-30.87M
Book Value Per Share	-0.25
Working Capital	48.03M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-79.01M
Capital Expenditures	n/a
Free Cash Flow	-79.01M
FCF Per Share	-$0.63

Full Cash Flow Statement

Margins

Gross margin is -113.71%, with operating and profit margins of -225.98% and -217.64%.

Gross Margin	-113.71%
Operating Margin	-225.98%
Pretax Margin	-216.41%
Profit Margin	-217.64%
EBITDA Margin	-221.51%
EBIT Margin	-225.98%
FCF Margin	n/a

Dividends & Yields

MRSN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.10%
Shareholder Yield	-3.10%
Earnings Yield	-172.77%
FCF Yield	-184.45%

Analyst Forecast

The average price target for MRSN is $5.75, which is 1,572.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.75
Price Target Difference	1,572.97%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	54.29%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MRSN has an Altman Z-Score of -11.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.94
Piotroski F-Score	3